Pregabalin Capsule
Product Images NDC 82804-950

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 82804-950). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82804-943-30 (Image 01)

This text provides information about a medication called Pregabalin 25mg in the form of capsules. It includes details such as the manufacturer (SK+F ESKAYEF PHARMACEUTICALS LIMITED) located in Bangladesh, the National Drug Code (NDC) number, the recommended storage conditions (20°-25°C or 68°-77°F), and a reminder to keep the medication out of the reach of children. Additionally, it highlights the appearance of the capsules and the need to dispense a Medication Guide to each patient.*

FDA Label Image

82804-944-30 (Image 02)

This text provides information on a medication called Pregabalin 50mg in capsule form. The capsules contain 50 mg of pregabalin, USP and are white in color. They are printed with "SK+F" on the cap, "PG 50" on the body, and an ink band. The medication is packaged by Proficient Rx LP and the product ID is ZP094430. It is recommended to dispense the accompanying Medication Guide to each patient. The manufacturer is SK+F ESKAYEF PHARMACEUTICALS LIMITED located in Bangladesh. The medication should be stored at 20°-25°C (68°-77°F) and kept out of the reach of children.*

FDA Label Image

82804-945-30 (Image 03)

This is a prescription medication information for Pregabalin 75mg capsules. Each capsule contains 75 mg of pregabalin, USP. The capsules are orange/white hard gelatin with "SK+F" printed on the cap and "PG 75" on the body. The product is packaged by Proficient Rx LP in Thousand Oaks, CA. It is advised to dispense the accompanying Medication Guide to each patient and store the medication at 20°-25°C (68°-77°F). The manufacturer is SK+F ESKAYEF PHARMACEUTICALS LIMITED located in Bangladesh. Remember to keep this medication out of reach of children.*

FDA Label Image

82804-946-30 (Image 04)

This text provides information about a medication called Pregabalin 100mg, which comes in a package containing #30 capsules. It instructs to dispense a Medication Guide to each patient and lists the contents of the capsule. The text also includes details such as the GTIN, expiration date, lot number, physical description of the capsule, product ID, manufacturer information, and storage instructions. It emphasizes keeping the medication out of the reach of children.*

FDA Label Image

82804-947-30 (Image 05)

This text provides information about a medication called Pregabalin, containing 150mg per capsule and packaged by Proficient Rx LP. The medication is prescribed with an accompanying Medication Guide for patients. The capsules are white and hard-shell with "SK+F" printed on the cap and "PG 150" on the body. The product ID is ZP094730 and it is manufactured by SK+F ESKAYEF PHARMACEUTICALS LIMITED in Bangladesh. It is advised to store the medication at 20°-25°C (68°-77°F) and keep it out of the reach of children.*

FDA Label Image

82804-948-30 (Image 06)

This text provides essential information about a medication called Pregabalin 200mg. The medication comes in a pack of 30 capsules and each capsule contains 200mg of pregabalin, USP. It is recommended to dispense a Medication Guide to each patient. The capsules are light orange hard gelatin with "SK+F" printed on the cap and "PG 200" on the body. The product is identified by the GTIN: 00382804948307 and Product ID: ZP094830. The manufacturer is SK+F ESKAYEF PHARMACEUTICALS LIMITED located in Bangladesh. Storage instructions advise keeping the medication at 20°-25°C (68°-77°F) and away from children.*

FDA Label Image

82804-949-30 (Image 07)

This text provides information about a medication called Pregabalin 225mg, supplied in a package of 30 capsules. The capsules are light orange and white, with specific markings on them. It is manufactured by SK+F ESKAYEF PHARMACEUTICALS LIMITED in Bangladesh. The recommended storage conditions are between 20°C to 25°C. Additionally, it is advised to keep this medication out of reach of children.*

FDA Label Image

82804-950-30 (Image 08)

This is information about Pregabalin 300mg capsules packed by Proficient Rx LP in Thousand Oaks, CA. Each capsule contains 300mg of pregabalin, USP and is in an orange/white hard gelatin capsule. The capsules are imprinted with "SK+F" on the cap and "PG 300" on the body. It is recommended to dispense a Medication Guide to each patient and store the medication at 20°-25°C (68°-77°F). The manufacturer is SK+F ESKAYEF PHARMACEUTICALS LIMITED located in Bangladesh.*

FDA Label Image

Chemical Structure (Pregabalin 01)

FDA Label Image

Figure 1 (Pregabalin 02)

This information provides details on the percentage of patients improved with different dosages of Pregabalin and a Placebo in relation to pain reduction from baseline. The data indicates varying levels of improvement based on the different dosages administered.*

FDA Label Image

Figure 2 (Pregabalin 03)

This is a chart displaying the percent of patients improved in pain when treated with Pregabalin 100 mg three times a day compared to a Placebo. The chart shows the percentage of improvement in pain from baseline across different points ranging from 210 to 290.*

FDA Label Image

Figure 3 (Pregabalin 04)

FDA Label Image

Figure 4 (Pregabalin 05)

This text provides data on the percentage of improvement in pain from baseline for patients taking Pregabalin at different dosages and a placebo. The values presented are for Pregabalin 200 mg three times a day, Pregabalin 100 mg three times a day, and Placebo.*

FDA Label Image

Figure 5 (Pregabalin 06)

This data is a comparison of the percentage of patients who showed improvement in pain from baseline after taking Pregabalin at different dosages (100 mg and 50 mg three times a day) compared to a placebo. The numbers provided show the percentage of improvement in pain for each group of patients.*

FDA Label Image

Figure 6 (Pregabalin 07)

FDA Label Image

Figure 7 (Pregabalin 08)

FDA Label Image

Figure 8 (Pregabalin 09)

This is a brief report on responder rates (%) for different doses of a medication compared to a placebo. The responder rates for the respective doses of 2.5 mg/kg/day and 10 mg/kg/day are 40.6%, 29.1%, and 22.6%. The placebo responder rate is 93. It appears that the responder rates vary based on the dosage levels.*

FDA Label Image

Figure 9 (Pregabalin 10)

This document shows the percent of patients improved based on different daily doses of Pregabalin and a placebo. The improvement in pain from the baseline is also depicted in the table provided.*

FDA Label Image

Figure 10 (Pregabalin 11)

FDA Label Image

Figure 11 (Pregabalin 12)

This text indicates the percentage of subjects improved over a period of time, specifically from baseline to week 12 with respect to Placebo and Pregabalin. The improvement percentages range from 80% to 100%.*

FDA Label Image

Figure 12 (Pregabalin 13)

This text shows the percentage of subjects who improved after receiving Pregabalin versus Placebo over a 16-week period. The data indicates the percentage of improvement at various time points, highlighting the efficacy of Pregabalin compared to Placebo.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.